ATA Safety First Trust Principal-Protected Certificates Linked TO A U.S.-Europe-Japan Basket

Apogee Technology, Inc. (AMEX:ATA), an emerging nanotechnology and micro-systems company that designs, develops and commercializes medical devices and sensor products, will hold a conference call to discuss its Third Quarter 2006 results and recent developments on Wednesday, November 15th 2006, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). This call is being webcast by CCBN and can be accessed at Apogee�s web site at www.apogeemems.com. The call can also be accessed via teleconference using the following dial-in and passcode numbers: Dial In # 866-578-5788 International Dial In # 617-213-8057 Participant Passcode 36449826 The webcast is also being distributed over CCBN�s Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN�s individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN�s Individual Investor Network. Institutional investors can access the call via CCBN�s password-protected event management site, StreetEvents (www.streetevents.com). About Apogee Technology, Inc. Apogee Technology designs, develops and commercializes proprietary medical device and sensor products using its MEMS and nanotechnology for the medical, automotive, industrial and consumer markets. The Company is developing its PyraDerm(TM) solution for enhanced transdermal drug delivery and has introduced a family of pressure sensors. Apogee's goal is to provide value-added and cost-savings solutions for our customers and, in so doing, to become a global leader in the sensors and medical device field. The Company operates a worldwide marketing and sales organization with offices in the US and Japan. For more information please visit our web site at: http://www.apogeemems.com. PyraDerm(TM), and Sensilica(TM) are trademarks of Apogee Technology, Inc. All other product names noted herein may be trademarks of their respective holders. Certain statements made herein that use the words "anticipate," "hope," "estimate," "project," "intend," "plan," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties, which could cause the actual results, performance or achievements of the company to be materially different from those that may be expressed or implied. Please refer to the Company's risk factors as set forth in the Company's filings with the Securities and Exchange Commission, including its reports on Forms 10-KSB and 10-QSB. Apogee Technology, Inc. (AMEX:ATA), an emerging nanotechnology and micro-systems company that designs, develops and commercializes medical devices and sensor products, will hold a conference call to discuss its Third Quarter 2006 results and recent developments on Wednesday, November 15th 2006, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). This call is being webcast by CCBN and can be accessed at Apogee's web site at www.apogeemems.com. The call can also be accessed via teleconference using the following dial-in and passcode numbers: Dial In # 866-578-5788 International Dial In # 617-213-8057 Participant Passcode 36449826 The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com). About Apogee Technology, Inc. Apogee Technology designs, develops and commercializes proprietary medical device and sensor products using its MEMS and nanotechnology for the medical, automotive, industrial and consumer markets. The Company is developing its PyraDerm(TM) solution for enhanced transdermal drug delivery and has introduced a family of pressure sensors. Apogee's goal is to provide value-added and cost-savings solutions for our customers and, in so doing, to become a global leader in the sensors and medical device field. The Company operates a worldwide marketing and sales organization with offices in the US and Japan. For more information please visit our web site at: http://www.apogeemems.com. PyraDerm(TM), and Sensilica(TM) are trademarks of Apogee Technology, Inc. All other product names noted herein may be trademarks of their respective holders. Certain statements made herein that use the words "anticipate," "hope," "estimate," "project," "intend," "plan," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties, which could cause the actual results, performance or achievements of the company to be materially different from those that may be expressed or implied. Please refer to the Company's risk factors as set forth in the Company's filings with the Securities and Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.